Endocrine and cellular physiology and pathology of the insulin-like growth factor acid-labile subunit
- 21 March 2024
- journal article
- review article
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 20 (7) , 414-425
Abstract
The acid-labile subunit (ALS) of the insulin-like growth factor (IGF) binding protein (IGFBP) complex, encoded in humans by IGFALS, has a vital role in regulating the endocrine transport and bioavailability of IGF-1 and IGF-2. Accordingly, ALS has a considerable influence on postnatal growth and metabolism. ALS is a leucine-rich glycoprotein that forms high-affinity ternary complexes with IGFBP-3 or IGFBP-5 when they are occupied by either IGF-1 or IGF-2. These complexes constitute a stable reservoir of circulating IGFs, blocking the potentially hypoglycaemic activity of unbound IGFs. ALS is primarily synthesized by hepatocytes and its expression is lower in non-hepatic tissues. ALS synthesis is strongly induced by growth hormone and suppressed by IL-1β, thus potentially serving as a marker of growth hormone secretion and/or activity and of inflammation. IGFALS mutations in humans and Igfals deletion in mice cause modest growth retardation and pubertal delay, accompanied by decreased osteogenesis and enhanced adipogenesis. In hepatocellular carcinoma, IGFALS is described as a tumour suppressor; however, its contribution to other cancers is not well delineated. This Review addresses the endocrine physiology and pathology of ALS, discusses the latest cell and proteomic studies that suggest emerging cellular roles for ALS and outlines its involvement in other disease states.Keywords
This publication has 184 references indexed in Scilit:
- The Matrisome Genes From Hepatitis B–Related Hepatocellular Carcinoma UnveiledHepatology Communications, 2021
- Longitudinal proteomic profiling provides insights into host response and proteome dynamics in COVID‐19 progressionProteomics, 2021
- Harnessing the paradoxical phenotypes of APOE ɛ2 and APOE ɛ4 to identify genetic modifiers in Alzheimer's diseaseAlzheimer's & Dementia, 2020
- Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factorsHepatology, 2012
- Genetic and plasma variation of insulin‐like growth factor binding proteins in relation to prostate cancer incidence and survivalThe Prostate, 2009
- Regulation of the components of the 150 kDa IGF binding protein complex in cocultures of rat hepatocytes and Kupffer Cells by 3?,5?-cyclic adenosine monophosphateJournal of Cellular Physiology, 2001
- Interleukin-1β Suppresses Growth Hormone-Induced Acid-Labile Subunit mRNA Levels and Secretion in Primary HepatocytesBiochemical and Biophysical Research Communications, 1998
- The effect of GH therapy on the immunoreactive forms and distribution of IGFBP-3, IGF-I, the acid-labile subunit, and growth rate in GH-deficient childrenEndocrine, 1997
- Synthesis of insulinlike growth factor binding proteins and of the acid-labile subunit in primary cultures of rat hepatocytes, of Kupffer cells, and in cocultures: Regulation by insulin, insulinlike growth factor, and growth hormoneHepatology, 1996
- Abnormal serum IGF-II transport in non-islet cell tumor hypoglycemia results from abnormalities of both IGF binding protein-3 and acid labile subunit and leads to elevation of serum free IGF-IIEndocrine, 1995